Molecule Name |
DB09095
|
DrugBank Groups |
Approved
|
Cluster No |
89
|
Smiles |
FC23(C1(C(=CC(=O)C=C1)C(F)CC2C4(CC(C)C(C4(CC3O)(C))C(=O)CO))(C))
|
Download |
mol2, pdbqt
|
TPSA |
74,6
|
Non-H Atoms |
28
|
Non-C/H Atoms |
6
|
Metal-Atoms |
0
|
Electronegative Atoms |
6
|
Stereo Centers |
9
|
Rotatable Bonds |
2
|
Rings Closures |
4
|
Small Rings |
4
|
Aromatic Rings |
0
|
Aromatic Atoms |
0
|
sp3-Atoms |
18
|
Symmetric atoms |
0
|
cLogS |
-3,883
|
MW |
394,456
|
cLogP |
1,9608
|
HBA |
4
|
HBD |
2
|
Ro5 violations |
0
|
Druglikeness |
2,82
|
DrugScore |
0,592855765623697
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
low
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-4,6108
|
Caco-2 Permeability 2 |
1,1829
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
0,6811
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
1,0751
|
Honey Bee Toxicity |
High HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
1,9733
|
Carcinogenicity (Three-class) |
Non-required
|